Metzelder, S., Schroeder, T., Finck, A., Scholl, S., Fey, M., Götze, K., . . . Kröger, M. (2012). High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses. Leukemia, 26(11), .
Chicago Style (17th ed.) CitationMetzelder, Stephan, et al. "High Activity of Sorafenib in FLT3-ITD-positive Acute Myeloid Leukemia Synergizes with Allo-immune Effects to Induce Sustained Responses." Leukemia 26, no. 11 (2012).
MLA (9th ed.) CitationMetzelder, Stephan, et al. "High Activity of Sorafenib in FLT3-ITD-positive Acute Myeloid Leukemia Synergizes with Allo-immune Effects to Induce Sustained Responses." Leukemia, vol. 26, no. 11, 2012.
Warning: These citations may not always be 100% accurate.